Skip to content

Neuroregenerative effects of transorbital extremely low-frequency low-amplitude pulsed electromagnetic therapy in retinal vein occlusion

Neuroregenerative effects of transorbital extremely low-frequency low-amplitude pulsed electromagnetic therapy in non-ischemic branch retinal vein occlusion

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ISRCTN
Registry ID
ISRCTN17248612
Enrollment
40
Registered
2026-03-25
Start date
2025-03-19
Completion date
Unknown
Last updated
2026-04-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Confirmed diagnosis of macular edema secondary to branch retinal vein occlusion or central retinal vein occlusion. Eye Diseases

Interventions

This research is a two-arm, longitudinal, prospective analysis of patients with non-ischemic superior temporal RVO. Randomization was generated using IBM SPSS Statistics software (version 20). Patient

Sponsors

Peoples' Friendship University of Russia
Lead Sponsor

Eligibility

Sex/Gender
All
Age
40 Years to 70 Years

Inclusion criteria

Inclusion criteria: 1. European 2. Men and women from 40 to 70 years old 3. Non-ischemic rvo of the superior temporal branch of the central retinal vein 4. Recent onset of retinal vein thrombosis =15 days 5. Central retinal thickness: between 350 µm and 600 µm 6. Total macular volume: between 9 mm³ and 15 mm³

Exclusion criteria

Exclusion criteria: 1. Presence of acute inflammatory diseases of the eye or systemic infections 2. Exudative retinal detachment 3. Poor response to the first anti-vegf injection (decreae of central retinal thickness < 20%) 4. Paroxysmal and mental disorders 5. Systemic thrombophilic disorders 6. Exacerbation of comorbid conditions during the study period 7. Intercurrent illness during the course of treatment 8. History of previously administered antiangiogenic therapy for the current condition 9. Failure to meet follow-up requirements 10. Presence or possibility of pregnancy 11. Decompensation of hypertension and diabetes mellitus 12. History of stroke or multiple sclerosis

Countries

Russian Federation

Contacts

Public ContactMustafa Al-Zamil
alzamil@mail.ru+7 89262893810

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Apr 17, 2026